XORTX Therapeutics, Inc. (XRTX)
0.9702
-0.04
(-3.94%)
USD |
NASDAQ |
Oct 20, 16:00
1.05
+0.08
(+8.23%)
After-Hours: 20:00
XORTX Therapeutics EPS Diluted (Quarterly) : -1.045 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.045 |
| March 31, 2026 | -0.5806 |
| December 31, 2025 | -0.45 |
| September 30, 2025 | -0.6686 |
| June 30, 2025 | -0.9472 |
| March 31, 2025 | -0.9348 |
| December 31, 2024 | 0.20 |
| September 30, 2024 | -0.2022 |
| June 30, 2024 | 0.0586 |
| March 31, 2024 | -1.243 |
| December 31, 2023 | 1.350 |
| September 30, 2023 | -0.6671 |
| June 30, 2023 | -0.8465 |
| March 31, 2023 | -0.9495 |
| December 31, 2022 | -1.326 |
| September 30, 2022 | -0.8289 |
| June 30, 2022 | -4.292 |
| Date | Value |
|---|---|
| March 31, 2022 | -1.873 |
| December 31, 2021 | 4.998 |
| September 30, 2021 | -6.347 |
| June 30, 2021 | -0.1704 |
| March 31, 2021 | -1.876 |
| December 31, 2020 | -0.4525 |
| September 30, 2020 | -0.4147 |
| June 30, 2020 | -0.3508 |
| March 31, 2020 | -0.0377 |
| December 31, 2019 | -0.2409 |
| September 30, 2019 | -0.168 |
| June 30, 2019 | -0.1951 |
| March 31, 2019 | -0.1931 |
| December 31, 2018 | -0.1872 |
| September 30, 2018 | -0.3945 |
| June 30, 2018 | -0.3576 |
| March 31, 2018 | -4.406 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Lexaria Bioscience Corp. | -1.204 |
| InMed Pharmaceuticals, Inc. | -1.434 |
| Target Group, Inc. (Canada) | -0.0004 |
| NervGen Pharma Corp. | -0.0925 |
| Milestone Pharmaceuticals, Inc. | -0.2063 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.691M |
| Total Expenses (Quarterly) | 1.691M |
| Enterprise Value | 0.7539M |
| Earnings Yield | -282.9% |
| Normalized Earnings Yield | -293.89 |